How to Cite
1.
Zamora Volio A. Uterine sarcomas. Rev.méd.sinerg. [Internet]. 2016Dec.2 [cited 2024Nov.22];1(12):10-4. Available from: https://revistamedicasinergia.com/index.php/rms/article/view/54
Abstract
Uterine sarcomas are tumors of mesodermal origin, 2% to 6% are malignant. The risk factors are exposure to previous radiation, tamoxifen, estrogen use, obesity.
Keywords
Tamoxifen. uterine sarcoma. pelvic disease. radiation. leiomyosarcoma.
References
1. Singh, R. (2014) Review literature on uterine carcinosarcoma. Journal of Cancer Research and Therapeutics, 10(3), 461-468.
2. El-Khalfaoui, K. et al. (2014) Current and future options in the management and treatment of uterine sarcoma. Therapeutic Advances in Medical Oncology, 6(1), 21-28.
3. Santos, P., Cunha, T. M. (2015) Uterine sarcomas: clinical presentation and MRI features. Diagnostic and Interventional Radiology, 21(1), 4-9.
4. Medina A., D. et al. (2013). Fundamentos prácticos de Ginecología general y oncológica. San José, Costa Rica: Editorial Nacional de Salud y Seguridad Social (EDNASSS). Págs. 150-154.
5. Berek, J. S. (Ed). (2012). Berek y Novak: Ginecología. Barcelona, España: Lippincott, Williams & Wilkins. Págs.1287-1294.
2. El-Khalfaoui, K. et al. (2014) Current and future options in the management and treatment of uterine sarcoma. Therapeutic Advances in Medical Oncology, 6(1), 21-28.
3. Santos, P., Cunha, T. M. (2015) Uterine sarcomas: clinical presentation and MRI features. Diagnostic and Interventional Radiology, 21(1), 4-9.
4. Medina A., D. et al. (2013). Fundamentos prácticos de Ginecología general y oncológica. San José, Costa Rica: Editorial Nacional de Salud y Seguridad Social (EDNASSS). Págs. 150-154.
5. Berek, J. S. (Ed). (2012). Berek y Novak: Ginecología. Barcelona, España: Lippincott, Williams & Wilkins. Págs.1287-1294.
Downloads
Download data is not yet available.